CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?

CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?

Abstract Chimeric antigen receptor T-cell (CAR-T) therapy has been prosperous in the treatment of patients with various types of relapsed/refractory (R/R) B-cell malignancies including diffuse large B-cell lymphoma (DLBCL), B-cell acute lymphoblastic leukemia (B-ALL), follicular lymphoma (FL), mantl...

Full description

Bibliographic Details
Main Authors: Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, Fatemeh Rahbarizadeh
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Stem Cell Research & Therapy
Subjects:
Chimeric antigen receptor
T-cell malignancies
Fratricide
T-cell aplasia
Natural killer cells
Cancer immunotherapy
Online Access:https://doi.org/10.1186/s13287-021-02595-0

Similar Items

Similar Items